文献速递艾滋病与性传播感染病毒性肝炎

欧洲与泰国HIV儿童青少年持续病毒抑制下免疫应答不良的患病率与临床结局:队列研究

Prevalence and Clinical Outcomes of Poor Immune Response Despite Virologically Suppressive Antiretroviral Therapy Among Children and Adolescents With Human Immunodeficiency Virus in Europe and Thailand: Cohort Study.
PubMed 文献 · Clin Infect Dis · 2020-01-01

该队列研究纳入2318例启动ART时<18岁且持续病毒抑制≥1年的儿童,评估免疫应答不良(PIR)的患病率与结局。病毒抑制1年时12%存在PIR,PIR与启动ART时年龄较大、免疫分期较差、乙肝合并感染及居住泰国相关。PIR组AIDS/死亡发生率为1052/10万人年,免疫应答组为261/10万人年,率比4.04(95%CI 1.83–8.92,P<.001)。

要点

  • 持续病毒抑制1年时约八分之一HIV儿童存在免疫应答不良。
  • 启动ART时年龄较大、免疫分期差、乙肝合并感染及居住泰国与PIR相关。
  • PIR儿童AIDS/死亡风险约为免疫应答者的4倍。

核心结论

  • 尽管持续病毒抑制,约八分之一儿童出现免疫应答不良,且PIR者AIDS/死亡风险较免疫应答者升高4倍。

研究设计与样本

  • 欧洲妊娠与儿科HIV队列协作组(EPPICC)16个队列的队列研究,纳入2318例启动ART时<18岁且持续病毒抑制(≤400 copies/mL)≥1年的儿童。

主要发现

  • 病毒抑制1年时12%存在PIR(按年龄的WHO高级/严重免疫抑制)。
  • 多变量分析中PIR与启动ART时年龄较大、免疫分期较差、乙肝合并感染及居住泰国相关(均P≤.03)。
  • PIR组AIDS/死亡率为1052(95%CI 547–2022)/10万人年,免疫应答组为261(95%CI 166–409)/10万人年。
  • AIDS/死亡率比为4.04(95%CI 1.83–8.92,P<.001)。

关键数值与推荐

  • PIR定义为持续病毒抑制1年时按年龄的WHO高级/严重免疫抑制。
  • 持续病毒抑制定义为HIV-1 RNA≤400 copies/mL持续≥1年。

临床怎么用

  • 对持续病毒抑制的HIV儿童应评估免疫应答,PIR者需加强监测与随访。
  • 启动ART时年龄较大、免疫分期差或合并乙肝感染的儿童应重点关注免疫应答不良风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: In human immunodeficiency virus (HIV)-positive adults, low CD4 cell counts despite fully suppressed HIV-1 RNA on antiretroviral therapy (ART) have been associated with increased risk of morbidity and mortality. We assessed the prevalence and outcomes of poor immune response (PIR) in children receiving suppressive ART. METHODS: Sixteen cohorts from the European Pregnancy and Paediatric HIV Cohort Collaboration (EPPICC) contributed data. Children <18 years at ART initiation, with sustained viral suppression (VS) (≤400 copies/mL) for ≥1 year were included. The prevalence of PIR (defined as World Health Organization advanced/severe immunosuppression for age) at 1 year of VS was described. Factors associated with PIR were assessed using logistic regression. Rates of acquired immunodeficiency syndrome (AIDS) or death on suppressive ART were calculated by PIR status. RESULTS: Of 2318 children included, median age was 6.4 years and 68% had advanced/severe immunosuppression at ART initiation. At 1 year of VS, 12% had PIR. In multivariable analysis, PIR was associated with older age and worse immunological stage at ART start, hepatitis B coinfection, and residing in Thailand (all P ≤ .03). Rates of AIDS/death (95% confidence interval) per 100 000 person-years were 1052 (547, 2022) among PIR versus 261 (166, 409) among immune responders; rate ratio of 4.04 (1.83, 8.92; P < .001). CONCLUSIONS: One in eight children in our cohort experienced PIR despite sustained VS. While the overall rate of AIDS/death was low, children with PIR had a 4-fold increase in risk of event as compared with immune responders.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. Prevalence and Clinical Outcomes of Poor Immune Response Despite Virologically Suppressive Antiretroviral Therapy Among Children and Adolescents With Human Immunodeficiency Virus in Europe and Thailand: Cohort Study. Clin Infect Dis. 2020. PMID: 30919882. doi:10.1093/cid/ciz253

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。